Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Cardiovascular Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $19.1 and in terms of global GDP, the market was 0.16%. Cardiovascular drugs was the fourth largest segment within the market accounting for 10.0% preceded and followed by central nervous ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $12.7 and in terms of global GDP, the market was 0.11%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.7% preceded and followed ... Read More
-
Ophthalmology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $6.6 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.4% preceded and followed by gastrointestinal drugs ... Read More
-
North America Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The anti-infective agents market in North America is expected to grow from US$ 45,331.11 ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $10.7 and in terms of global GDP, the market was 0.09%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.6% preceded and followed ... Read More
-
Genito-Urinary Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $5.2 and in terms of global GDP, the market was 0.04%. Genito-urinary drugs was the eleventh largest segment within the market accounting for 2.7% preceded and followed by dermatology drugs ... Read More
-
Oncology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $26.0 and in terms of global GDP, the market was 0.23%. Oncology drugs was the second largest segment within the market accounting for 13.7% preceded and followed by anti-infective drugs ... Read More
-
Dermatology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $6.4 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ophthalmology drugs ... Read More
-
Hematology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $4.2 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.7% ... Read More
-
Central Nervous System Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... In terms of per capita consumption, the market was $22.0 and in terms of global GDP, the market was 0.19%. Central nervous system drugs was the third largest segment within the market accounting for 11.6% ... Read More
-
Gastrointestinal Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $9.3 and in terms of global GDP, the market was 0.08%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.9% preceded and followed by metabolic disorders ... Read More
-
Respiratory Diseases Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $18.5 and in terms of global GDP, the market was 0.16%. Respiratory diseases drugs was the fifth largest segment within the market accounting for 9.8% preceded and followed ... Read More
-
Sjogren’s Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others (Pain Relief Medication and late phase drug)), by type (Primary and Secondary), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Sjogren’s syndrome is systematic autoimmune disorder which effect the entire body, along ... Read More
-
Live Cell Imaging Market, By Product (Equipment, Consumables, and Software and Services), By Application (Cell Biology, Developmental Biology, Stem Cell Biology, Drug Discovery, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Live cell imaging is the study of living cells using time-lapse microscopy. This technique has revolutionized cell biology by facilitating ... Read More
-
Primary Biliary Cirrhosis (Primary Biliary Cholangitis) - Drug Pipeline Landscape, 2022
... are destroyed eventually. Researcher experts consider it as an autoimmune disease in which the body turns against its own cells and the exact cause is unknown. Researchers believe this autoimmune response may be triggered by ... Read More
-
Global Allergic Conjunctivitis Market Size study, By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids), By Disease Type (Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC)), By Distribution Channel (Hospital Pharmacies, Drug stores & Retail Pharmacies, Online providers), and Regional Forecasts 2022-2028
... Pharmacies, Online providers), and Regional Forecasts 2022-2028 Global Allergic Conjunctivitis Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than one million incidence cases of HER2- BC across 16 pharmaceutical markets. There are several marketed innovator drugs for the treatment of HER2- BC, mostly kinase inhibitors. A total of seven ... Read More
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 300,000 diagnosed incidence cases of HAP across seven major pharmaceutical markets. There are six leading marketed drugs for the treatment of HAP, and Merck is a key player in the ... Read More
-
NLP in Healthcare and Life Sciences Market by Component (Solutions and Services), NLP Type (Statistical, Hybrid), NLP Technique (IVR, OCR), Application (Clinical Trail Matching, Drug Discovery), End Users and Region - Global Forecast to 2027
... The NLP in healthcare and life sciences market size to grow from USD 2.2 billion in 2022 to USD 7.2 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 27.1% during the forecast ... Read More
-
IMCIVREE (Setmelanotide), Drug Insight and Market Forecast – 2032
... IMCIVREE (Setmelanotide) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
TIGLUTIK Drug Insight and Market Forecast – 2032
... for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
NA Underactive Bladder Market - Industry Trends and Forecast to 2029
... report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation North America Underactive Bladder Market, By Treatment (Pharmacotherapy, Surgical Methods, ... Read More
-
MEA Underactive Bladder Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation Middle East and Africa Underactive Bladder Market, By ... Read More
-
MIJ821 Emerging Drug Insight and Market Forecast – 2032
... of the MIJ821 for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Frontotemporal Dementia - Market Insight, Epidemiology And Market Forecast - 2032
... as the Frontotemporal Dementia market trends in the United States, the EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Frontotemporal Dementia market report provides current treatment practices, emerging drugs, market share ... Read More
Research Assistance
